Literature DB >> 30899964

Norbert Wagner1, Frauke Assmus2, Gabriele Arendt3, Erika Baum4, Ulrich Baumann5, Christian Bogdan6,7, Gerd Burchard6,8, Dirk Föll9, Edeltraut Garbe6,10, Jane Hecht2, Ulf Müller-Ladner11, Tim Niehues12, Klaus Überla6,13, Sabine Vygen-Bonnet14, Thomas Weinke15, Miriam Wiese-Posselt2, Michael Wojcinski16, Fred Zepp6,17.   

Abstract

Year:  2019        PMID： 30899964     DOI： 10.1007/s00103-019-02905-1

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN： 1436-9990            Impact factor:   1.513


× No keyword cloud information.
  121 in total

1.  Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Authors:  Diane Lacaille; J Antonio Avina-Zubieta; Eric C Sayre; Michal Abrahamowicz
Journal:  Ann Rheum Dis       Date:  2016-12-28       Impact factor: 19.103

Review 2.  ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).

Authors:  K L Winthrop; X Mariette; J T Silva; E Benamu; L H Calabrese; A Dumusc; J S Smolen; J M Aguado; M Fernández-Ruiz
Journal:  Clin Microbiol Infect       Date:  2018-02-12       Impact factor: 8.067

Review 3.  Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.

Authors:  Eric D Shah; Jeremy P Farida; Corey A Siegel; Kelly Chong; Gil Y Melmed
Journal:  Inflamm Bowel Dis       Date:  2017-04       Impact factor: 5.325

4.  Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.

Authors:  Anna-Birgitte Aga; Elisabeth Lie; Till Uhlig; Inge Christoffer Olsen; Ada Wierød; Synøve Kalstad; Erik Rødevand; Knut Mikkelsen; Tore K Kvien; Espen A Haavardsholm
Journal:  Ann Rheum Dis       Date:  2013-11-27       Impact factor: 19.103

Review 5.  Biologic-associated infections in pediatric rheumatology.

Authors:  Gerd Horneff
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

Review 6.  Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis.

Authors:  Manjari Lahiri; William G Dixon
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-06-12       Impact factor: 4.098

Review 7.  Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications.

Authors:  John E McKinnon; Kathleen Maksimowicz-McKinnon
Journal:  Transl Res       Date:  2015-09-05       Impact factor: 7.012

8.  Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

Authors:  Michele F Doran; Cynthia S Crowson; Gregory R Pond; W Michael O'Fallon; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2002-09

Review 9.  Infections and Biological Therapy in Patients with Rheumatic Diseases.

Authors:  Fabiola Atzeni; Alberto Batticciotto; Ignazio F Masala; Rossella Talotta; Maurizio Benucci; Piercarlo Sarzi-Puttini
Journal:  Isr Med Assoc J       Date:  2016 Mar-Apr       Impact factor: 0.892

10.  Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab.

Authors:  Joachim Listing; Jörn Kekow; Bernhard Manger; Gerd-Rüdiger Burmester; Dagmar Pattloch; Angela Zink; Anja Strangfeld
Journal:  Ann Rheum Dis       Date:  2013-11-29       Impact factor: 19.103
View more
  27 in total

Review 1.  [Indications for varicella zoster and herpes zoster vaccination in multiple sclerosis: current situation].

Authors:  Alexander Winkelmann; Micha Löbermann; Uwe K Zettl
Journal:  Nervenarzt       Date:  2019-12       Impact factor: 1.214

Review 2.  Pregnancy and Autoimmune Disease.

Authors:  Waltraut Maria Merz; Rebecca Fischer-Betz; Kerstin Hellwig; Georg Lamprecht; Ulrich Gembruch
Journal:  Dtsch Arztebl Int       Date:  2022-03-04       Impact factor: 8.251

Review 3.  [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].

Authors:  Heinz Wiendl; Ralf Gold; Thomas Berger; Tobias Derfuss; Ralf Linker; Mathias Mäurer; Martin Stangel; Orhan Aktas; Karl Baum; Martin Berghoff; Stefan Bittner; Andrew Chan; Adam Czaplinski; Florian Deisenhammer; Franziska Di Pauli; Renaud Du Pasquier; Christian Enzinger; Elisabeth Fertl; Achim Gass; Klaus Gehring; Claudio Gobbi; Norbert Goebels; Michael Guger; Aiden Haghikia; Hans-Peter Hartung; Fedor Heidenreich; Olaf Hoffmann; Zoë R Hunter; Boris Kallmann; Christoph Kleinschnitz; Luisa Klotz; Verena Leussink; Fritz Leutmezer; Volker Limmroth; Jan D Lünemann; Andreas Lutterotti; Sven G Meuth; Uta Meyding-Lamadé; Michael Platten; Peter Rieckmann; Stephan Schmidt; Hayrettin Tumani; Martin S Weber; Frank Weber; Uwe K Zettl; Tjalf Ziemssen; Frauke Zipp
Journal:  Nervenarzt       Date:  2021-07-23       Impact factor: 1.214

Review 4.  Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.

Authors:  Torsten Kucharzik; Sibylle Koletzko; Klaus Kannengiesser; Axel Dignass
Journal:  Dtsch Arztebl Int       Date:  2020-08-17       Impact factor: 5.594

Review 5.  [Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?]

Authors:  J Braun; U Kiltz; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2020-09-18       Impact factor: 1.372

Review 6.  [STIKO vaccination recommendations : Vaccination of immunodeficient patients and vaccination against COVID-19].

Authors:  Christian Bogdan
Journal:  Hautarzt       Date:  2021-01-18       Impact factor: 0.751

7. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513

Review 8.  [Travel vaccinations in rheumatic diseases : Specific considerations in children and adults].

Authors:  T Welzel; A Wörner; U Heininger
Journal:  Z Rheumatol       Date:  2020-11       Impact factor: 1.372

9.  [How well are patients with inflammatory rheumatic diseases protected against measles?]

Authors:  U Kiltz; A Celik; S Tsiami; X Baraliakos; I Andreica; D Kiefer; B Bühring; J Braun
Journal:  Z Rheumatol       Date:  2020-09-15       Impact factor: 1.372

10.  [Immunogenicity and safety of high dose vs. standard dose of inactivated influenza vaccine in patients with rheumatoid arthritis].

Authors:  Michaela Christenn
Journal:  Z Rheumatol       Date:  2021-06-25       Impact factor: 1.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.